You are here

Drug makers to supply 230,000 more infant RSV shots to the US

Primary tabs

Drug makers to supply 230,000 more infant RSV shots to the US

Fri, 2023-12-15 10:08 — mike kraft

AstraZeneca, Sanofi to supply 230,000 more RSV infant shots to US market The makers of a respiratory syncytial virus (RSV) immunization for infants that has been in tight supply will deliver an additional 230,000 doses in January, the White House said on Thursday, after U.S. government officials met with the companies to discuss meeting winter demand. Trevor Hunnicutt,Michael Erman Reuters

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Groups this Group Post belongs to:

- Private group -

Log in or register to post comments

Workflow history

Revision ID	Field name	Date	Old state	New state name	By	Comment	Operations
			No state	No state

Page loaded in 0.483 seconds.